AbstractAntibiotics, which have previously revolutionized medical research, are now under jeopardy due to the emergence of multidrug resistance among dangerous microorganisms. The abuse of antimicrobial medicines, as well as the unavailability of newer treatments owing to stringent regulatory restrictions and decreased commercial incentives, has been blamed for the antimicrobial resistance problem. Emergent bacteria, resistance mechanisms, and antimicrobial drugs must all be studied in order to slow the rate of resistance. Health-care environments, as well as the environment and agricultural sectors, need multidisciplinary approaches. Probiotics, antibodies, and vaccinations are examples of progressive alternative treatments that have showed encouraging outcomes in studies, suggesting that they may be used as preventative or supplementary therapy in the future.
Das et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: